Some review and maybe something new.
Recent research on fluid biomarkers in multiple sclerosis (MS) frames an emerging picture of two aspects of the disease: inflammatory activity measured with neurofilament light chain (NfL), and disease progression independent of relapses, with promising results suggested by emerging markers like glial fibrillary acidic protein (GFAP).
Great article. Anything that helps the understanding PIRA sounds hopeful.
JANUARY 2018 ARTIST OF THE MONTH! Celebrating the Work of Artists Affected by Multiple Sclerosis
On Patient Decision Aid in Multiple Sclerosis
You have relapsing Remitting Multiple Sclerosis.PET Brain Scans Find ‘Smoldering’ Inflammation in Multiple Sclerosis Patients
Meet the Cambridge Scientist Who could be on the Verge of Curing Multiple Sclerosis 
